Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Thrombopoietin Receptor Agonist”

51 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 51 results

Not applicableStudy completedNCT01618734
What this trial is testing

Eltrombopag and Romiplostim Used Alternatively in Patients With Immune Thrombopenia (ITP): Efficacy and Safety.

Who this might be right for
Immune ThrombocytopeniaThrombopoietin Receptor Agonist
Henri Mondor University Hospital 50
Post-approval studies (Phase 4)Looking for participantsNCT07133659
What this trial is testing

Exploring the Efficacy, Safety of a Modified Starting Dosage of Avatrombopag in Immune Throbocytopenia (ITP) - a Pilot Study

Who this might be right for
ITP - Immune Thrombocytopenia
Al-Mustansiriyah University 25
Testing effectiveness (Phase 2)Study completedNCT00961064
What this trial is testing

A Pilot Study of a Thrombopoietin-Receptor Agonist, Eltrombopag, in Patients With Low to Int-2 Risk Myelodysplastic Syndrome (MDS)

Who this might be right for
Myelodysplastic SyndromesThrombocytopenia
National Heart, Lung, and Blood Institute (NHLBI) 30
Early research (Phase 1)Study completedNCT00903422
What this trial is testing

Eltrombopag Treatment of Thrombocytopenia in Subjects With Advanced Myelodysplastic Syndrome (MDS) or Secondary Acute Myeloid Leukemia After MDS (sAML/MDS)

Who this might be right for
Myelodysplastic Syndrome
GlaxoSmithKline 98
Post-approval studies (Phase 4)UnknownNCT06009965
What this trial is testing

Efficacy of IST Combined With TPO-RA in the Treatment of AA and Establishment of a Recurrence Prediction System

Who this might be right for
Aplastic AnemiaCSADrug Therapy
Peking Union Medical College Hospital 210
Large-scale testing (Phase 3)Not Yet RecruitingNCT07786922
What this trial is testing

Avatrombopag in Adults With Aplastic Anemia Who Did Not Respond to, Cannot Receive, or Had Return of Disease After Standard Treatment

Who this might be right for
Aplastic Anemia
Swedish Orphan Biovitrum 26
Testing effectiveness (Phase 2)Looking for participantsNCT07586813
What this trial is testing

Romiplostim N01 Plus ATRA for Persistent Isolated Chemotherapy-Induced Thrombocytopenia After Complete Remission of Gastrointestinal Solid Tumors

Who this might be right for
Persistent Isolated Chemotherapy-Induced ThrombocytopeniaChemotherapy-Induced ThrombocytopeniaGastrointestinal Neoplasms+2 more
Peking University People's Hospital 220
Testing effectiveness (Phase 2)Looking for participantsNCT07421167
What this trial is testing

Assess the Tolerability of Ianalumab (VAY736) With Investigator's Choice Thrombopoietin Receptor Agonist (IC TPO-RA) in Patients With Primary Immune Thrombocytopenia (ITP)

Who this might be right for
Primary Immune Thrombocytopenia (ITP)Primary Evans Syndrome (ES)
Novartis Pharmaceuticals 164
Not applicableStudy completedNCT06408324
What this trial is testing

Evaluation of the Use of Thrombopoietin Receptor Agonists in Adults With Primary ITP in Europe

Who this might be right for
Primary Immune Thrombocytopenia (ITP)
European Research Consortium on ITP 275
Not applicableStudy completedNCT04943042
What this trial is testing

An Observational, Multicenter Study to Evaluate the Use and Effectiveness of Doptelet® in Patients With ITP

Who this might be right for
Immune ThrombocytopeniaITP
Swedish Orphan Biovitrum 199
Post-approval studies (Phase 4)Study completedNCT01098487
What this trial is testing

A Longitudinal 2-year Bone Marrow Study of Eltrombopag in Previously Treated Adults, With Chronic Immune (Idiopathic) Thrombocytopenic Purpura (ITP)

Who this might be right for
Purpura, Thrombocytopaenic, Idiopathic
GlaxoSmithKline 167
Testing effectiveness (Phase 2)Looking for participantsNCT07535645
What this trial is testing

Baricitinib for Post-HSCT Persistent Thrombocytopenia

Who this might be right for
Persistent ThrombocytopeniaAllogeneic Hematopoietic Stem Cell Transplantation
Peking University People's Hospital 28
Large-scale testing (Phase 3)Study completedNCT00828750
What this trial is testing

Clinical Evaluation of Eltrombopag in Chronic Idiopathic Thrombocytopenic Purpura (ITP)

Who this might be right for
Idiopathic Thrombocytopenic PurpuraPurpura, Thrombocytopenic, Idiopathic
GlaxoSmithKline 19
Not applicableUnknownNCT05846529
What this trial is testing

Safety of Oral Thrombopoietin Receptor Agonist in Pediatric Chronic ITP

Who this might be right for
Thrombopoietin Receptor Agonist
Assiut University 100
Testing effectiveness (Phase 2)Study completedNCT01890746
What this trial is testing

A Safety and Efficacy Study of Eltrombopag in Subjects With AML

Who this might be right for
Acute Leukaemia
Novartis Pharmaceuticals 148
Early research (Phase 1)Study completedNCT00358540
What this trial is testing

Dose Finding Study Of Oral Eltrombopag In Patients With Sarcoma Receiving Adriamycin And Ifosfamide

Who this might be right for
Thrombocytopaenia
GlaxoSmithKline 18
Post-approval studies (Phase 4)Study completedNCT03119974
What this trial is testing

Rate of Prolonged Response After Stopping Thrombopoietin-receptor Agonists Treatment in ITP

Who this might be right for
Persistent or Chronic ITP
Assistance Publique - Hôpitaux de Paris 48
Testing effectiveness (Phase 2)Study completedNCT00102726
What this trial is testing

SB-497115 (Oral Thrombopoietin Receptor Agonist) Versus Placebo In Adult Cancer Patients Receiving Chemotherapy

Who this might be right for
Thrombocytopaenia
GlaxoSmithKline 183
Testing effectiveness (Phase 2)Study completedNCT00102739
What this trial is testing

SB-497115 (Oral Thrombopoietin Receptor Agonist) Versus Placebo In Adults With Refractory Immune Thrombocytopenic Purpura (ITP)

Who this might be right for
Purpura, Thrombocytopaenic, Idiopathic
GlaxoSmithKline 99
Testing effectiveness (Phase 2)Looking for participantsNCT06478537
What this trial is testing

TPO-RA Treatment on Immune Tolerance Induction of ITP Patients With Sustained Platelet Recovery After Treatment Termination

Who this might be right for
Immune Thrombocytopenia
Peking Union Medical College Hospital 56
Next Page